Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 121.59B | 119.76B | 115.22B | 114.88B | 117.11B | 77.33B |
Gross Profit | 25.60B | 25.25B | 21.94B | 24.45B | 32.23B | 16.14B |
EBITDA | 17.33B | 17.00B | 14.46B | 16.01B | 24.19B | 9.48B |
Net Income | 8.37B | 8.36B | 6.83B | 8.07B | 13.69B | 4.05B |
Balance Sheet | ||||||
Total Assets | 125.22B | 131.46B | 124.50B | 131.25B | 122.07B | 95.51B |
Cash, Cash Equivalents and Short-Term Investments | 3.98B | 7.16B | 9.68B | 10.93B | 16.93B | 9.07B |
Total Debt | 23.63B | 19.20B | 16.39B | 22.52B | 20.16B | 21.46B |
Total Liabilities | 54.67B | 59.54B | 58.01B | 69.18B | 64.57B | 49.63B |
Stockholders Equity | 67.72B | 69.09B | 63.74B | 59.35B | 54.92B | 43.38B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.45B | 7.94B | -5.36B | 13.00B | -4.20B |
Operating Cash Flow | 0.00 | 6.98B | 13.20B | 5.13B | 17.40B | 6.93B |
Investing Cash Flow | 0.00 | -8.90B | -4.94B | -10.08B | -4.39B | -11.18B |
Financing Cash Flow | 0.00 | -645.00M | -9.50B | -1.08B | -5.17B | -4.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥61.06B | 9.03 | 3.05% | 2.72% | 5.77% | ||
78 Outperform | ¥194.88B | 13.84 | 2.29% | 3.26% | -13.75% | ||
77 Outperform | ¥104.99B | 11.57 | 3.45% | 8.18% | 28.35% | ||
76 Outperform | ¥31.89B | 6.41 | 4.18% | 3.47% | 33.32% | ||
76 Outperform | ¥60.23B | 13.16 | 1.83% | 5.20% | -1.83% | ||
72 Outperform | ¥166.35B | 14.05 | 1.50% | 12.70% | 34.96% | ||
62 Neutral | $10.36B | 6.35 | 0.80% | 2.84% | 3.10% | -36.03% |
KH Neochem Co., Ltd. announced the acquisition of 186,200 of its own shares at a cost of 500,697,300 yen through market purchases on the Tokyo Stock Exchange. This acquisition is part of a larger plan authorized by the Board of Directors to buy back up to 2,500,000 shares, aiming to enhance shareholder value and optimize capital structure.
KH Neochem Co., Ltd. reported a significant improvement in its financial performance for the first half of 2025, with a 5.1% increase in net sales and substantial rises in operating and ordinary income. The company’s strategic focus has resulted in a notable increase in basic earnings per share, reflecting its strong market positioning and operational efficiency. The announcement indicates a positive outlook for stakeholders, with the company maintaining its dividend forecast and showing resilience in its financial health.
KH Neochem Co., Ltd. announced the acquisition of 426,500 of its own shares, amounting to approximately 1.02 billion yen, through market purchases on the Tokyo Stock Exchange during May 2025. This move is part of a larger plan approved by the Board of Directors to acquire up to 2.5 million shares, with a total budget of 5 billion yen, aimed at enhancing shareholder value and optimizing capital structure.
KH Neochem Co., Ltd. has announced an additional contribution to its Board Benefit Trust, a move aimed at securing shares for future benefits under its performance-linked share-based remuneration plan. This strategic decision reflects the company’s commitment to aligning the interests of its directors and corporate officers with long-term shareholder value, potentially enhancing its market position and stakeholder confidence.
KH Neochem Co., Ltd. reported a 6.8% increase in net sales for the first quarter of 2025, with operating income rising by 8.5% compared to the previous year. Despite a decrease in comprehensive income by 30%, the company forecasts continued growth in sales and income for the full year, indicating a positive outlook for stakeholders.